Redefining the therapeutic landscape for CRPC

Beyond Hormone Therapy for Prostate Cancer with PARP inhibitors

(2011) Johann Sebastian de Bono et al.   CANCER CELL

Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth

(2011) David J. Mulholland et al.   CANCER CELL

Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

(2011) Brett S. Carver et al.   CANCER CELL

Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer

(2011) J. Chad Brenner et al.   CANCER CELL

Translating Scientific Advancement into Clinical Benefit for Castration-Resistant Prostate Cancer Patients

(2011) G. Attard et al.   CLINICAL CANCER RESEARCH

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

(2011) Karim Fizazi et al.   LANCET

Abiraterone and Increased Survival in Metastatic Prostate Cancer

(2011) Johann S. de Bono et al.   NEW ENGLAND JOURNAL OF MEDICINE

Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers

(2011) Y Wang et al.   ONCOGENE